PMID- 36686454 OWN - NLM STAT- MEDLINE DCOM- 20230124 LR - 20240226 IS - 1664-2392 (Print) IS - 1664-2392 (Electronic) IS - 1664-2392 (Linking) VI - 13 DP - 2022 TI - Methanol extract of Inonotus obliquus improves type 2 diabetes mellitus through modifying intestinal flora. PG - 1103972 LID - 10.3389/fendo.2022.1103972 [doi] LID - 1103972 AB - Type 2 diabetes mellitus (T2DM) poses a significant risk to human health. Previous research demonstrated that Inonotus obliquus possesses good hypolipidemic, anti-inflammatory, and anti-tumor properties. In this research, we aim to investigate the potential treatment outcomes of Inonotus obliquus for T2DM and discuss its favourable influences on the intestinal flora. The chemical composition of Inonotus obliquus methanol extracts (IO) was analyzed by ultra-high-performance liquid chromatography-Q extractive-mass spectrometry. IO significantly improved the blood glucose level, blood lipid level, and inflammatory factor level in T2DM mice, and effectively alleviated the morphological changes of colon, liver and renal. Acetic acid, propionic acid, and butyric acid levels in the feces of the IO group were restored. 16S rRNA gene sequencing revealed that the intestinal flora composition of mice in the IO group was significantly modulated. Inonotus obliquus showed significant hypoglycemic and hypolipidemic effects with evident anti-inflammatory activity and improved the morphological structure of various organs and cells. Inonotus obliquus increased the levels of short-chain fatty acids in the environment by increasing the population of certain bacteria that produce acid, such as Alistipes and Akkermansia, which are beneficial to improve intestinal flora disorders and maintain intestinal flora homeostasis. Meanwhile, Inonotus obliquus further alleviated T2DM symptoms in db/db mice by down-regulating the high number of microorganisms that are dangerous, such as Proteobacteria and Rikenellaceae_RC9_gut_group and up-regulating the abundance of beneficial bacteria such as Odoribacter and Rikenella. Therefore, this study provides a new perspective for the treatment of T2DM by demonstrating that drug and food homologous active substances could relieve inflammation via regulating intestinal flora. CI - Copyright (c) 2023 Ye, Wu, Xu, Cen, Ni, Chen, Zheng and Liu. FAU - Ye, Xuewei AU - Ye X AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Wu, Kefei AU - Wu K AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Xu, Langyu AU - Xu L AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Cen, Yingxin AU - Cen Y AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Ni, Jiahui AU - Ni J AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Chen, Junyao AU - Chen J AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Zheng, Wenxin AU - Zheng W AD - Key Laboratory of Pollution Exposure and Health Intervention of Zhejiang Province, Department of Basic Medical Sciences, Shulan International Medical College, Zhejiang Shuren University, Hangzhou, China. FAU - Liu, Wei AU - Liu W AD - Institute of Plant Protection and Microbiology, Zhejiang Academy of Agricultural Sciences, Hangzhou, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230106 PL - Switzerland TA - Front Endocrinol (Lausanne) JT - Frontiers in endocrinology JID - 101555782 RN - Y4S76JWI15 (Methanol) RN - 0 (RNA, Ribosomal, 16S) RN - 0 (Plant Extracts) RN - 0 (Anti-Inflammatory Agents) RN - Inonotus obliquus SB - IM MH - Humans MH - Mice MH - Animals MH - Methanol MH - *Diabetes Mellitus, Type 2/drug therapy MH - *Gastrointestinal Microbiome MH - RNA, Ribosomal, 16S MH - Plant Extracts/pharmacology/therapeutic use MH - Anti-Inflammatory Agents/therapeutic use PMC - PMC9852891 OTO - NOTNLM OT - Inonotus obliquus OT - SCFAs OT - T2DM OT - db/db mice OT - intestinal flora COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2023/01/24 06:00 MHDA- 2023/01/25 06:00 PMCR- 2022/01/01 CRDT- 2023/01/23 04:50 PHST- 2022/11/21 00:00 [received] PHST- 2022/12/19 00:00 [accepted] PHST- 2023/01/23 04:50 [entrez] PHST- 2023/01/24 06:00 [pubmed] PHST- 2023/01/25 06:00 [medline] PHST- 2022/01/01 00:00 [pmc-release] AID - 10.3389/fendo.2022.1103972 [doi] PST - epublish SO - Front Endocrinol (Lausanne). 2023 Jan 6;13:1103972. doi: 10.3389/fendo.2022.1103972. eCollection 2022.